| Name | transmembrane protein 92 |
| Description | Located in nucleoplasm. [provided by Alliance of Genome Resources, Mar 2025] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nA careful review of the provided literature (‐"}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "7"}]}, {"type": "t", "text": "reveals an extensive focus on chemokine-mediated cellular trafficking and activation—particularly highlighting the role of CXCR3 and its ligands in coordinating immune cell recruitment, effector function, and resolution of inflammation in contexts ranging from cancer immunotherapy and autoimmunity to infectious and central nervous system disorders. Notably, however, none of these studies specifically address or mention TMEM92. In contrast, they collectively underscore mechanisms by which extracellular chemoattractants modulate immune responses and tissue remodeling."}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFor example, several investigations detail how CXCR3 signaling directs the migration of T lymphocytes, natural killer cells, and other leukocytes into tumors or inflamed tissues—thereby influencing clinical outcomes in cancer, autoimmune diseases, and even wound repair."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "8", "end_ref": "17"}]}, {"type": "t", "text": " These reports dissect post‐translational chemokine modification, receptor internalization, and the fine regulation of effector versus memory T cell fates—all of which contribute to a nuanced understanding of chemokine biology in health and disease."}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nFurther mechanistic studies extend these insights by examining receptor–ligand selectivity, intracellular signaling cascades, and how chemokine signals are integrated to control immune cell positioning in diverse tissue microenvironments."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "18", "end_ref": "27"}]}, {"type": "t", "text": " In aggregate, while these studies richly characterize chemokine receptor systems (notably CXCR3) and their critical immunomodulatory roles, none provide evidence regarding the function or involvement of TMEM92. As such, the literature surveyed here does not offer direct insights into TMEM92’s biological role; future research is therefore needed to determine whether TMEM92 might interact with, modulate, or be regulated by similar chemokine‐driven pathways in immune or other cellular contexts."}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Melvyn T Chow, Aleksandra J Ozga, Rachel L Servis, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunity (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.immuni.2019.04.010"}], "href": "https://doi.org/10.1016/j.immuni.2019.04.010"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "31097342"}], "href": "https://pubmed.ncbi.nlm.nih.gov/31097342"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "M E Mikucki, D T Fisher, J Matsuzaki, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Non-redundant requirement for CXCR3 signalling during tumoricidal T-cell trafficking across tumour vascular checkpoints."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Commun (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ncomms8458"}], "href": "https://doi.org/10.1038/ncomms8458"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26109379"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26109379"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Karen M Lammers, Ruliang Lu, Julie Brownley, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Gliadin induces an increase in intestinal permeability and zonulin release by binding to the chemokine receptor CXCR3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Gastroenterology (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1053/j.gastro.2008.03.023"}], "href": "https://doi.org/10.1053/j.gastro.2008.03.023"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18485912"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18485912"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Marco Wendel, Ioanna E Galani, Elisabeth Suri-Payer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/0008-5472.CAN-08-1440"}], "href": "https://doi.org/10.1158/0008-5472.CAN-08-1440"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18922917"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18922917"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Dianhua Jiang, Jiurong Liang, Jennifer Hodge, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Regulation of pulmonary fibrosis by chemokine receptor CXCR3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Clin Invest (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1172/JCI16861"}], "href": "https://doi.org/10.1172/JCI16861"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15254596"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15254596"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Gabriele S V Campanella, Andrew M Tager, Joseph K El Khoury, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chemokine receptor CXCR3 and its ligands CXCL9 and CXCL10 are required for the development of murine cerebral malaria."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0801544105"}], "href": "https://doi.org/10.1073/pnas.0801544105"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18347328"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18347328"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Rosa Barreira da Silva, Melissa E Laird, Nader Yatim, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dipeptidylpeptidase 4 inhibition enhances lymphocyte trafficking, improving both naturally occurring tumor immunity and immunotherapy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Immunol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ni.3201"}], "href": "https://doi.org/10.1038/ni.3201"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26075911"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26075911"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Tessa Bergsbaken, Michael J Bevan "}, {"type": "b", "children": [{"type": "t", "text": "Proinflammatory microenvironments within the intestine regulate the differentiation of tissue-resident CD8⁺ T cells responding to infection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Immunol (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/ni.3108"}], "href": "https://doi.org/10.1038/ni.3108"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25706747"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25706747"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Angelika Rappert, Ingo Bechmann, Tatyana Pivneva, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2004)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.2451-04.2004"}], "href": "https://doi.org/10.1523/JNEUROSCI.2451-04.2004"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15456824"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15456824"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "John A Belperio, Michael P Keane, Marie D Burdick, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Critical role for CXCR3 chemokine biology in the pathogenesis of bronchiolitis obliterans syndrome."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.169.2.1037"}], "href": "https://doi.org/10.4049/jimmunol.169.2.1037"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12097412"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12097412"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Bram Slütter, Lecia L Pewe, Susan M Kaech, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Lung airway-surveilling CXCR3(hi) memory CD8(+) T cells are critical for protection against influenza A virus."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunity (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.immuni.2013.09.013"}], "href": "https://doi.org/10.1016/j.immuni.2013.09.013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24238342"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24238342"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Marcus Müller, Sally L Carter, Markus J Hofer, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CXCR3 signaling reduces the severity of experimental autoimmune encephalomyelitis by controlling the parenchymal distribution of effector and regulatory T cells in the central nervous system."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.179.5.2774"}], "href": "https://doi.org/10.4049/jimmunol.179.5.2774"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17709491"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17709491"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Heather D Hickman, Glennys V Reynoso, Barbara F Ngudiankama, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CXCR3 chemokine receptor enables local CD8(+) T cell migration for the destruction of virus-infected cells."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Immunity (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.immuni.2015.02.009"}], "href": "https://doi.org/10.1016/j.immuni.2015.02.009"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25769612"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25769612"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Makoto Kurachi, Junko Kurachi, Fumiko Suenaga, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Chemokine receptor CXCR3 facilitates CD8(+) T cell differentiation into short-lived effector cells leading to memory degeneration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20102101"}], "href": "https://doi.org/10.1084/jem.20102101"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21788406"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21788406"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Urs Christen, Dorian B McGavern, Andrew D Luster, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Among CXCR3 chemokines, IFN-gamma-inducible protein of 10 kDa (CXC chemokine ligand (CXCL) 10) but not monokine induced by IFN-gamma (CXCL9) imprints a pattern for the subsequent development of autoimmune disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.171.12.6838"}], "href": "https://doi.org/10.4049/jimmunol.171.12.6838"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14662890"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14662890"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Yoshihisa Okamoto, Eduardo J Folco, Manabu Minami, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Adiponectin inhibits the production of CXC receptor 3 chemokine ligands in macrophages and reduces T-lymphocyte recruitment in atherogenesis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Circ Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1161/CIRCRESAHA.107.164988"}], "href": "https://doi.org/10.1161/CIRCRESAHA.107.164988"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17991878"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17991878"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Ye Htun Oo, Vanessa Banz, Dean Kavanagh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CXCR3-dependent recruitment and CCR6-mediated positioning of Th-17 cells in the inflamed liver."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Hepatol (2012)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jhep.2012.07.008"}], "href": "https://doi.org/10.1016/j.jhep.2012.07.008"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "22796894"}], "href": "https://pubmed.ncbi.nlm.nih.gov/22796894"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Jenny H Xie, Naomi Nomura, Min Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antibody-mediated blockade of the CXCR3 chemokine receptor results in diminished recruitment of T helper 1 cells into sites of inflammation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Leukoc Biol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1189/jlb.1102573"}], "href": "https://doi.org/10.1189/jlb.1102573"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "12773510"}], "href": "https://pubmed.ncbi.nlm.nih.gov/12773510"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Bo Zhang, Ying Kai Chan, Bao Lu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CXCR3 mediates region-specific antiviral T cell trafficking within the central nervous system during West Nile virus encephalitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.180.4.2641"}], "href": "https://doi.org/10.4049/jimmunol.180.4.2641"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18250476"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18250476"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Liping Liu, Deren Huang, Masaru Matsui, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Severe disease, unaltered leukocyte migration, and reduced IFN-gamma production in CXCR3-/- mice with experimental autoimmune encephalomyelitis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.176.7.4399"}], "href": "https://doi.org/10.4049/jimmunol.176.7.4399"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16547278"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16547278"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Cecelia C Yates, Diana Whaley, Priya Kulasekeran, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Delayed and deficient dermal maturation in mice lacking the CXCR3 ELR-negative CXC chemokine receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Am J Pathol (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.2353/ajpath.2007.061092"}], "href": "https://doi.org/10.2353/ajpath.2007.061092"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17600132"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17600132"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Richard J Bodnar, Cecelia C Yates, Margaret E Rodgers, et al. "}, {"type": "b", "children": [{"type": "t", "text": "IP-10 induces dissociation of newly formed blood vessels."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Cell Sci (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1242/jcs.048793"}], "href": "https://doi.org/10.1242/jcs.048793"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19470579"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19470579"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Andrea Meiser, Anja Mueller, Emma L Wise, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The chemokine receptor CXCR3 is degraded following internalization and is replenished at the cell surface by de novo synthesis of receptor."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.180.10.6713"}], "href": "https://doi.org/10.4049/jimmunol.180.10.6713"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18453591"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18453591"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Jacob E Kohlmeier, Tres Cookenham, Shannon C Miller, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CXCR3 directs antigen-specific effector CD4+ T cell migration to the lung during parainfluenza virus infection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Immunol (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.4049/jimmunol.0902022"}], "href": "https://doi.org/10.4049/jimmunol.0902022"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19734208"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19734208"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Gabriele S V Campanella, Richard A Colvin, Andrew D Luster "}, {"type": "b", "children": [{"type": "t", "text": "CXCL10 can inhibit endothelial cell proliferation independently of CXCR3."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0012700"}], "href": "https://doi.org/10.1371/journal.pone.0012700"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20856926"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20856926"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Chanyu Yue, Shudan Shen, Jiehui Deng, et al. "}, {"type": "b", "children": [{"type": "t", "text": "STAT3 in CD8+ T Cells Inhibits Their Tumor Accumulation by Downregulating CXCR3/CXCL10 Axis."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cancer Immunol Res (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1158/2326-6066.CIR-15-0014"}], "href": "https://doi.org/10.1158/2326-6066.CIR-15-0014"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26025380"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26025380"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Georgina Xanthou, Timothy J Williams, James E Pease "}, {"type": "b", "children": [{"type": "t", "text": "Molecular characterization of the chemokine receptor CXCR3: evidence for the involvement of distinct extracellular domains in a multi-step model of ligand binding and receptor activation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Eur J Immunol (2003)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1002/eji.200324235"}], "href": "https://doi.org/10.1002/eji.200324235"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "14515277"}], "href": "https://pubmed.ncbi.nlm.nih.gov/14515277"}]}]}]}
|
| Proteins | TMM92_HUMAN |
| NCBI Gene ID | 162461 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
TMEM92 has 3,183 functional associations with biological entities spanning 8 categories (molecular profile, organism, functional term, phrase or reference, disease, phenotype or trait, chemical, cell line, cell type or tissue, gene, protein or microRNA, sequence feature) extracted from 73 datasets.
Click the + buttons to view associations for TMEM92 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TMEM92 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray | tissue samples with high or low expression of TMEM92 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by Microarray dataset. | |
| Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of TMEM92 gene relative to other tissues from the Allen Brain Atlas Prenatal Human Brain Tissue Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TMEM92 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of TMEM92 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of TMEM92 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TMEM92 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of TMEM92 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of TMEM92 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CM4AI KOLF21J CRISPRi Gene Perturbation Atlas | gene perturbations changing expression of TMEM92 gene from the CM4AI KOLF21J CRISPRi Gene Perturbation Atlas dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores | cellular components containing TMEM92 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Curated Protein Localization Evidence Scores 2025 | cellular components containing TMEM92 protein from the COMPARTMENTS Curated Protein Localization Evidence Scores 2025 dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores | cellular components co-occuring with TMEM92 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with TMEM92 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of TMEM92 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with TMEM92 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Disease Associations | diseases associated with TMEM92 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with TMEM92 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by TMEM92 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with TMEM92 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with TMEM92 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TMEM92 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of TMEM92 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of TMEM92 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing TMEM92 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with TMEM92 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of TMEM92 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing TMEM92 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of TMEM92 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TMEM92 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of TMEM92 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of TMEM92 gene from the GEO Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of TMEM92 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of TMEM92 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing TMEM92 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GTEx eQTL 2025 | SNPs regulating expression of TMEM92 gene from the GTEx eQTL 2025 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of TMEM92 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of TMEM92 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TMEM92 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GTEx Tissue-Specific Aging Signatures | tissue samples with high or low expression of TMEM92 gene relative to other tissue samples from the GTEx Tissue-Specific Aging Signatures dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with TMEM92 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with TMEM92 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with TMEM92 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles | cell lines with high or low expression of TMEM92 gene relative to other cell lines from the Heiser et al., PNAS, 2011 Cell Line Gene Expression Profiles dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of TMEM92 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of TMEM92 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of TMEM92 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of TMEM92 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of TMEM92 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of TMEM92 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of TMEM92 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of TMEM92 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of TMEM92 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain TMEM92 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MotifMap Predicted Transcription Factor Targets | transcription factors regulating expression of TMEM92 gene predicted using known transcription factor binding site motifs from the MotifMap Predicted Transcription Factor Targets dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of TMEM92 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of TMEM92 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for TMEM92 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of TMEM92 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles | cell types and tissues with high or low DNA methylation of TMEM92 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue DNA Methylation Profiles dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of TMEM92 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at TMEM92 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| Rummagene Transcription Factor Associations 2026 | transcription factors regulating expression of TMEM92 gene from the Rummagene Transcription Factor Associations 2026 dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of TMEM92 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of TMEM92 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| Sci-Plex Drug Perturbation Signatures | drug perturbations changing expression of TMEM92 gene from the Sci-Plex Drug Perturbation Signatures dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of TMEM92 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of TMEM92 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of TMEM92 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores | tissues with high expression of TMEM92 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of TMEM92 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Experimental Tissue Protein Expression Evidence Scores | tissues with high expression of TMEM92 protein in proteomics datasets from the TISSUES Experimental Tissue Protein Expression Evidence Scores dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with TMEM92 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |